Full-Time

Assembly Technician

Updated on 8/23/2026

Deadline 9/8/26
TRIUMF

TRIUMF

501-1,000 employees

Canada’s particle accelerator research facility

Compensation Overview

CA$51.1k/yr

Vancouver, BC, Canada

In Person

Category
Hardware Engineering (1)
Required Skills
Microsoft Office
Assembly

Get referred to TRIUMF

See people who can refer or advise you

Requirements
  • Successfully complete the TRIUMF in-house radiation safety training course and be designated as a TRIUMF Nuclear Energy Worker.
  • Have broad knowledge in the area of expertise.
  • Have experience with wiring, soldering and rework, mechanical assembly, and relevant equipment and tools.
  • Have knowledge of computer operation.
  • Have at least 3–5 years of practical experience.
  • Be legally able to work in Canada on a permanent basis as a Canadian citizen or permanent resident.
Responsibilities
  • Kit parts for modules or printed circuit boards, order parts from outside suppliers, and input jobs into the TRIUMF machine shop.
  • Construct modules involving electrical, electronic, and mechanical assembly, and perform limited testing of completed modules.
  • Order cable and connectors, cut cables, and assemble them using approved tooling.
  • Test using computer-aided test setups and label connector assemblies, including BNC, SHV, SMA, coaxial, ribbon, high-voltage, MS, modular, and various crimp assemblies.
  • Work on surface-mount assemblies, including component identification and manual soldering.
  • Maintain relevant records for the TRIUMF accounting department and enter timesheets into the computer system.
Desired Qualifications
  • Experience with Microsoft Office and Altium Designer software.

TRIUMF is Canada’s national particle accelerator centre in Vancouver, running a large accelerator complex for research in particle and nuclear physics. Researchers use its facilities to study fundamental matter and to develop practical technologies, including medical isotopes and materials science applications. It differentiates itself through nationwide university collaborations, a multidisciplinary team, and a direct path from basic discoveries to real-world benefits. Its goal is to advance science while building Canadian leadership in science and technology and training the next generation of scientists, engineers, and leaders.

Company Size

501-1,000

Company Stage

Grant

Total Funding

$293.2M

Headquarters

Vancouver, Canada

Founded

1968

Get referred to TRIUMF

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Canada granted TRIUMF $399.1 million over 2025-2030, a 50% baseline increase.
  • BC Cancer’s 2025 cyclotron build adds capacity, redundancy, and clinical isotope demand near TRIUMF.
  • ALPHA’s May 2026 Nature result strengthens TRIUMF’s global reputation and recruitment pull.

What critics are saying

  • The main cyclotron goes offline January 2026 through May 2027, pressuring throughput.
  • TRIUMF depends on government funding; the $399.1 million package renews in March 2030.
  • If ARIEL or IAMI commissioning slips, Canada’s isotope leadership shifts to U.S. and European labs.

What makes TRIUMF unique

  • TRIUMF anchors Canada’s particle-physics access, bridging CERN collaborations and domestic accelerator expertise.
  • IAMI gives TRIUMF rare medical-isotope infrastructure, with operations targeted for 2026.
  • ARIEL extends TRIUMF’s scientific moat, targeting 5000 radioactive isotope beam hours by 2029.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Wellness Program

Parental Leave

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
SNOLAB
May 21st, 2025
Former SNOLAB director elected Fellow of the Royal Society

Smith left SNOLAB in 2021 to take on the role of executive director and CEO of TRIUMF in Vancouver.

Government of British Columbia
Jan 30th, 2024
BC Gov News

The Province is investing $32 million to support this work through $21 million to BC Cancer for the new cyclotron and radiopharmacy laboratory and approximately $11 million to TRIUMF to advance research.